RLAY · Relay Therapeutics, Inc.

$19.70 -1.04 (-5.01%) At close · Aug 20

Market Cap

$4.32B

219.14M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sanjiv K. Patel	President and Chief Executive Officer	$707,846	—	—	$3,513,900	$424,708	—	$4,646,454
Thomas Catinazzo	Chief Financial Officer	$486,100	—	—	$874,500	$194,440	$13,573	$1,568,613
Brian R. Adams	Former Chief Legal Officer	$291,182	—	—	$874,500	—	$11,647	$1,177,329

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sanjiv K. Patel	President and Chief Executive Officer	$697,385	—	$11,963,485	—	$418,431	—	$13,079,301
Donald Bergstrom	M.D., Ph.D. President, Research & Development	$543,375	$600,000	$5,212,800	—	$244,519	$12,703	$6,613,397
Peter Rahmer	Chief Corporate Development Officer	$455,400	$600,000	$3,713,903	—	$182,160	$12,173	$4,963,636
Thomas Catinazzo	Chief Financial Officer	$481,276	—	$3,713,903	—	$192,510	$13,305	$4,400,994
Brian R. Adams	Chief Legal Officer	$455,400	—	$3,713,903	—	$182,160	$13,800	$4,365,263

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sanjiv K. Patel	President and Chief Executive Officer	$673,802	—	—	$18,692,755	$404,281	—	$19,770,838
Donald Bergstrom	M.D., Ph.D. President, Research & Development	$525,000	$600,000	$2,931,929	$4,272,790	$236,250	$7,094	$8,573,063
Peter Rahmer	Chief Corporate Development Officer	$440,000	—	$3,554,966	$2,600,863	$176,000	$10,617	$6,782,446
Thomas Catinazzo	Chief Financial Officer	$465,000	—	$1,855,945	$2,699,210	$186,000	$12,994	$5,219,149
Brian R. Adams	Chief Legal Officer	$440,000	—	$1,588,054	$2,295,006	$176,000	$11,715	$4,510,775

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sanjiv K. Patel	President and Chief Executive Officer	$641,716	—	—	$7,095,094	$385,030	—	$8,121,840
Donald Bergstrom	M.D., Ph.D. President, Research & Development	$500,000	—	$1,323,681	$1,748,402	$200,000	$11,255	$3,783,338
Thomas Catinazzo	Chief Financial Officer	$420,000	—	$800,323	$1,057,117	$168,000	$11,825	$2,457,265
Brian R. Adams	Chief Legal Officer	$420,000	—	$800,323	$1,057,117	$168,000	$10,534	$2,455,974
Peter Rahmer	Chief Corporate Development Officer	$400,000	—	$800,323	$1,057,117	$160,000	$10,517	$2,427,957

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sanjiv K. Patel	President and Chief Executive Officer	$602,550	—	—	$7,516,145	$414,253	—	$8,532,948
Donald Bergstrom	M.D., Ph.D. President, Research & Development	$475,000	—	$1,198,716	$1,618,816	$237,500	$9,760	$3,539,792
Brian R. Adams	Chief Legal Officer	$401,700	—	$543,548	$734,038	$200,850	$9,499	$1,889,635
Thomas Catinazzo	Chief Financial Officer	$381,100	—	$543,548	$734,038	$166,731	$10,862	$1,836,279
Andy Porter	Chief Administrative Officer	$412,000	—	$479,500	$647,545	$206,000	$9,564	$1,754,609

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sanjiv K. Patel	President and Chief Executive Officer	$585,000	—	—	$2,589,131	$402,188	—	$3,576,319
Donald Bergstrom	M.D., Ph.D. President, Research & Development	$440,000	—	—	$435,276	$220,000	$9,816	$1,105,092
Brian R. Adams	Chief Legal Officer	$390,000	—	—	$232,148	$170,625	$7,428	$800,201

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sanjiv K. Patel	President and Chief Executive Officer	$585,000	—	—	$2,590,671	$353,925	—	$3,529,596
Donald Bergstrom	President, Research & Development	$406,850	—	—	$330,652	$179,014	—	$916,516
General Counsel	—	$356,213	—	—	$165,326	$97,958	—	$619,497
Brian R. Adams	Chief Legal Officer	$356,213	—	—	$165,326	$97,958	—	$619,497

Executive changes

Person	Role	Change	Effective	Filed
Habib Dable	member of the Board	Appointed	2025-11-04	2025-11-06
Lonnel Coats	member of the Board	Appointed	2025-11-04	2025-11-06
Jami Ruben	member of the Board and as a member of Audit Committee of the Board	Resigned	2025-06-08	2025-06-11
Sekar Kathiresan, M.D.	class III director	Appointed	2022-07-25	2022-07-27
Dipchand (Deep) Nishar	Class III director	Resigned	2021-12-08	2021-12-09

Key facts CIK 1812364 CUSIP 75943R102 13F (30d) 249 filings 243 filers Visit website Investor relations